3M Attest Super Rapid Readout Biological Indicator, REF 1492V; used to qualify or monitor dynamic...

FDA Device Recall #Z-2637-2023 — Class II — August 22, 2023

Recall Summary

Recall Number Z-2637-2023
Classification Class II — Moderate risk
Date Initiated August 22, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm 3M Company - Health Care Business
Location Saint Paul, MN
Product Type Devices
Quantity 79500 devices

Product Description

3M Attest Super Rapid Readout Biological Indicator, REF 1492V; used to qualify or monitor dynamic-air-removal steam sterilization cycles

Reason for Recall

Specific lots of 3M Attest Super Rapid Readout Biological Indicators (1492V), 3M Attest Super Rapid 5 Steam-Plus Challenge (41482V, 41482VF), and 3M Attest Super Rapid Readout Steam Challenge (1496V) may contain biological indicators with a cap that melts, deforms and/or cracks following a steam sterilization cycle of 132¿C and 135¿C.

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Belgium, Canada, China, Colombia, Hong Kong, Italy, Japan, Peru, Poland, South Korea, Spain, Taiwan.

Lot / Code Information

UDI/DI: 50707387762969 (shipper), 30707387762965 (carton); Lot codes: 33P3X3, exp. 12/29/2024; 33P4NH, exp. 01/01/2025

Other Recalls from 3M Company - Health Care Business

Recall # Classification Product Date
Z-0743-2025 Class II Clarity Precision Grip Attachments, for use in ... Nov 22, 2024
Z-0038-2025 Class II 3M Tegaderm CHG, Chlorhexidine Gluconate I.V. S... Aug 14, 2024
Z-1633-2024 Class II 3M Durapore Surgical Tape, Catalog Number 1538-118 Mar 20, 2024
Z-1475-2024 Class II 3M Tube Securement Device, Small, 1.7 IN/PO x 2... Feb 20, 2024
Z-1169-2024 Class II 3M Specialty Blade Assembly, REF 9660,70-2011-8... Jan 12, 2024

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.